Go Pro

Moore Capital Management LP Sells 52,475 Shares of Teleflex Incorporated $TFX

Teleflex logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Moore Capital Management cut its Teleflex stake by 50.1%, selling 52,475 shares during the second quarter and retaining 52,175 shares valued at approximately $6.6 million.
  • Teleflex reported quarterly EPS of $1.76, beating estimates by $0.48, while revenue rose 28.9% year over year to $570.33 million. The company issued fiscal 2026 EPS guidance of $6.90–$7.20.
  • Analysts maintain a consensus “Hold” rating with an average price target of $152.90, while Teleflex declared a quarterly dividend of $0.34 per share, equivalent to a 1.0% annual yield.
  • Five stocks to consider instead of Teleflex.

Moore Capital Management LP decreased its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 50.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 52,175 shares of the medical technology company's stock after selling 52,475 shares during the quarter. Moore Capital Management LP owned 0.12% of Teleflex worth $6,614,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in TFX. BlackRock Inc. acquired a new position in shares of Teleflex during the 2nd quarter worth about $688,537,000. Jupiter Topco LLC bought a new position in Teleflex during the 2nd quarter worth approximately $550,456,000. Janus Henderson Group PLC boosted its stake in Teleflex by 1.1% during the 1st quarter. Janus Henderson Group PLC now owns 4,291,311 shares of the medical technology company's stock worth $513,281,000 after acquiring an additional 45,199 shares during the last quarter. AQR Capital Management LLC grew its holdings in Teleflex by 478.1% during the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company's stock valued at $287,603,000 after purchasing an additional 1,956,811 shares during the period. Finally, State Street Corp grew its holdings in Teleflex by 1.5% during the fourth quarter. State Street Corp now owns 1,478,776 shares of the medical technology company's stock valued at $180,470,000 after purchasing an additional 22,111 shares during the period. Institutional investors own 95.62% of the company's stock.

Teleflex Price Performance

TFX stock opened at $139.81 on Monday. The stock has a 50-day moving average price of $133.86 and a two-hundred day moving average price of $126.05. The stock has a market cap of $5.92 billion, a PE ratio of -6.00, a price-to-earnings-growth ratio of 0.93 and a beta of 0.81. The company has a current ratio of 2.60, a quick ratio of 2.12 and a debt-to-equity ratio of 0.94. Teleflex Incorporated has a 1 year low of $100.18 and a 1 year high of $145.00.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.48. The firm had revenue of $570.33 million for the quarter, compared to the consensus estimate of $559.59 million. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%.The company's revenue for the quarter was up 28.9% on a year-over-year basis. During the same quarter last year, the business posted $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Equities analysts forecast that Teleflex Incorporated will post 7.26 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Friday, August 14th will be given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend is Friday, August 14th. Teleflex's dividend payout ratio (DPR) is currently -5.84%.

Wall Street Analysts Forecast Growth

TFX has been the topic of a number of recent analyst reports. Raymond James Financial reissued an "outperform" rating and set a $150.00 price target on shares of Teleflex in a research report on Friday, May 8th. Royal Bank Of Canada upgraded shares of Teleflex from a "sector perform" rating to an "outperform" rating and upped their price objective for the company from $135.00 to $155.00 in a research report on Friday, May 8th. Truist Financial raised their price objective on Teleflex from $143.00 to $150.00 and gave the stock a "hold" rating in a research note on Monday, August 10th. Wells Fargo & Company lifted their target price on Teleflex from $130.00 to $138.00 and gave the stock an "equal weight" rating in a report on Friday, May 8th. Finally, Needham & Company LLC boosted their target price on Teleflex from $159.00 to $170.00 and gave the company a "buy" rating in a research note on Tuesday, August 25th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $152.90.

Check Out Our Latest Analysis on Teleflex

Teleflex Company Profile

(Free Report)

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

Read More

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Teleflex Right Now?

Before you consider Teleflex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.

While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines